Bloomberg Law
March 21, 2023, 9:37 PM

Edwards Lifesciences Sued Over $300 Million Tied to Heart Device

Mike Leonard
Mike Leonard
Legal Reporter

Edwards Lifesciences Corp. is facing litigation in Delaware over claims that it’s on the hook for $300 million after acquiring a smaller biotech company solely to shelve its flagship heart valve repair device.

The lawsuit accuses the life sciences giant of duping Valtech Cardio Ltd. investors into deferring $350 million in compensation—out of up to $690 million—as part of a scheme to block commercialization of the “Cardioband” system while Edwards developed a competing product. The upfront sale price was $340 million, according to the complaint made public Tuesday.

“As defendants continue to sideline Cardioband for their financial benefit"—depriving former Valtech ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.